Publication:
Dengue: a continuing global threat.

dc.contributor.authorSimmons, Cameron
dc.date.accessioned2018-09-14T11:15:09Z
dc.date.available2018-08-09T10:14:16Z
dc.date.available2018-09-14T11:15:09Z
dc.date.issued2010-12en_US
dc.description.abstractDengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
dc.identifier.urihttps://demo7.dspace.org/handle/10673/221
dc.languageengen_US
dc.titleDengue: a continuing global threat.en_US
dc.typeJournal Article
dspace.entity.typePublication
relation.isAuthorOfPublicationb1b2c768-bda1-448a-a073-fc541e8b24d9
relation.isAuthorOfPublication.latestForDiscoveryb1b2c768-bda1-448a-a073-fc541e8b24d9
Files
Collections